# Philip Morris International Inc.: financial statements, quarterly

PM · NYSE · CIK 1413329 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pm.md) · [Financials](/companies/pm/financials.md) · [Filings](/companies/pm/filings.md) · [Insiders](/companies/pm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [9.0 d](/filings/0001628280-26-005939.md) | [8.8](/filings/0001413329-25-000094.md) | [9.5](/filings/0001413329-25-000150.md) | [9.9](/filings/0001628280-25-046179.md) | [9.7 d](/filings/0001628280-26-005939.md) | [9.3](/filings/0001628280-26-027019.md) | [10.1](/filings/0001628280-26-049493.md) | [10.8](/filings/0001628280-26-066976.md) | [10.4 d](/filings/0001628280-26-005939.md) | [10.1](/filings/0001628280-26-027019.md) | [11.2](/filings/0001628280-26-049493.md) | [11.4](/filings/0001628280-26-066976.md) |
| Cost of revenue | $bn | [3.5 d](/filings/0001628280-26-005939.md) | [3.2](/filings/0001413329-25-000094.md) | [3.3](/filings/0001413329-25-000150.md) | [3.4](/filings/0001628280-25-046179.md) | [3.4 d](/filings/0001628280-26-005939.md) | [3.0](/filings/0001628280-26-027019.md) | [3.3](/filings/0001628280-26-049493.md) | [3.5](/filings/0001628280-26-066976.md) | [3.6 d](/filings/0001628280-26-005939.md) | [3.2](/filings/0001628280-26-027019.md) | [3.5](/filings/0001628280-26-049493.md) | [3.6](/filings/0001628280-26-066976.md) |
| Gross profit | $bn | [5.6 d](/filings/0001628280-26-005939.md) | [5.6](/filings/0001413329-25-000094.md) | [6.1](/filings/0001413329-25-000150.md) | [6.5](/filings/0001628280-25-046179.md) | [6.3 d](/filings/0001628280-26-005939.md) | [6.3](/filings/0001628280-26-027019.md) | [6.9](/filings/0001628280-26-049493.md) | [7.4](/filings/0001628280-26-066976.md) | [6.8 d](/filings/0001628280-26-005939.md) | [6.9](/filings/0001628280-26-027019.md) | [7.7](/filings/0001628280-26-049493.md) | [7.9](/filings/0001628280-26-066976.md) |
| Operating income | $bn | [2.9 d](/filings/0001628280-26-005939.md) | [3.0](/filings/0001413329-25-000094.md) | [3.4](/filings/0001413329-25-000150.md) | [3.7](/filings/0001628280-25-046179.md) | [3.3 d](/filings/0001628280-26-005939.md) | [3.5](/filings/0001628280-26-027019.md) | [3.7](/filings/0001628280-26-049493.md) | [4.3](/filings/0001628280-26-066976.md) | [3.4 d](/filings/0001628280-26-005939.md) | [3.9](/filings/0001628280-26-027019.md) | [4.5](/filings/0001628280-26-049493.md) | [4.9](/filings/0001628280-26-066976.md) |
| Income tax | $bn | [0.3 d](/filings/0001628280-26-005939.md) | [0.7](/filings/0001413329-25-000094.md) | [0.7](/filings/0001413329-25-000150.md) | [0.7](/filings/0001628280-25-046179.md) | [0.9 d](/filings/0001628280-26-005939.md) | [0.7](/filings/0001628280-26-027019.md) | [0.7](/filings/0001628280-26-049493.md) | [0.8](/filings/0001628280-26-066976.md) | [0.7 d](/filings/0001628280-26-005939.md) | [0.7](/filings/0001628280-26-027019.md) | [1.0](/filings/0001628280-26-049493.md) | [1.0](/filings/0001628280-26-066976.md) |
| Net income | $bn | [2.2 d](/filings/0001628280-26-005939.md) | [2.1](/filings/0001413329-25-000094.md) | [2.4](/filings/0001413329-25-000150.md) | [3.1](/filings/0001628280-25-046179.md) | [(0.6) d](/filings/0001628280-26-005939.md) | [2.7](/filings/0001628280-26-027019.md) | [3.0](/filings/0001628280-26-049493.md) | [3.5](/filings/0001628280-26-066976.md) | [2.1 d](/filings/0001628280-26-005939.md) | [2.4](/filings/0001628280-26-027019.md) | [2.8](/filings/0001628280-26-049493.md) | [3.3](/filings/0001628280-26-066976.md) |
| Diluted EPS | $ per share | not reported | [1.38](/filings/0001413329-25-000094.md) | [1.54](/filings/0001413329-25-000150.md) | [1.97](/filings/0001628280-25-046179.md) | not reported | [1.72](/filings/0001628280-26-027019.md) | [1.95](/filings/0001628280-26-049493.md) | [2.23](/filings/0001628280-26-066976.md) | not reported | [1.56](/filings/0001628280-26-027019.md) | [1.80](/filings/0001628280-26-049493.md) | [2.12](/filings/0001628280-26-066976.md) |
| Basic EPS | $ per share | not reported | [1.38](/filings/0001413329-25-000094.md) | [1.54](/filings/0001413329-25-000150.md) | [1.98](/filings/0001628280-25-046179.md) | not reported | [1.72](/filings/0001628280-26-027019.md) | [1.95](/filings/0001628280-26-049493.md) | [2.23](/filings/0001628280-26-066976.md) | not reported | [1.56](/filings/0001628280-26-027019.md) | [1.80](/filings/0001628280-26-049493.md) | [2.12](/filings/0001628280-26-066976.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.1](/filings/0001413329-25-000013.md) | [4.0](/filings/0001413329-24-000087.md) | [4.8](/filings/0001413329-24-000145.md) | [4.3](/filings/0001413329-24-000172.md) | [4.2](/filings/0001628280-26-005939.md) | [4.4](/filings/0001413329-25-000094.md) | [4.1](/filings/0001413329-25-000150.md) | [4.0](/filings/0001628280-25-046179.md) | [4.9](/filings/0001628280-26-066976.md) | [5.5](/filings/0001628280-26-027019.md) | [6.0](/filings/0001628280-26-049493.md) | [6.7](/filings/0001628280-26-066976.md) |
| Current assets | $bn | [19.8](/filings/0001413329-25-000013.md) | [20.9](/filings/0001413329-24-000087.md) | [21.0](/filings/0001413329-24-000145.md) | [20.8](/filings/0001413329-24-000172.md) | [20.2](/filings/0001628280-26-005939.md) | [22.2](/filings/0001413329-25-000094.md) | [23.4](/filings/0001413329-25-000150.md) | [22.7](/filings/0001628280-25-046179.md) | [24.4](/filings/0001628280-26-066976.md) | [25.6](/filings/0001628280-26-027019.md) | [26.0](/filings/0001628280-26-049493.md) | [25.8](/filings/0001628280-26-066976.md) |
| Total assets | $bn | [65.3](/filings/0001413329-25-000013.md) | [65.3](/filings/0001413329-24-000087.md) | [65.8](/filings/0001413329-24-000145.md) | [66.9](/filings/0001413329-24-000172.md) | [61.8](/filings/0001628280-26-005939.md) | [65.1](/filings/0001413329-25-000094.md) | [68.5](/filings/0001413329-25-000150.md) | [67.1](/filings/0001628280-25-046179.md) | [69.2](/filings/0001628280-26-066976.md) | [68.9](/filings/0001628280-26-027019.md) | [68.3](/filings/0001628280-26-049493.md) | [66.7](/filings/0001628280-26-066976.md) |
| Current liabilities | $bn | [26.4](/filings/0001413329-25-000013.md) | [22.2](/filings/0001413329-24-000087.md) | [22.4](/filings/0001413329-24-000145.md) | [23.4](/filings/0001413329-24-000172.md) | [22.9](/filings/0001628280-26-005939.md) | [28.1](/filings/0001413329-25-000094.md) | [28.1](/filings/0001413329-25-000150.md) | [26.7](/filings/0001628280-25-046179.md) | [25.4](/filings/0001628280-26-066976.md) | [26.2](/filings/0001628280-26-027019.md) | [26.5](/filings/0001628280-26-049493.md) | [25.2](/filings/0001628280-26-066976.md) |
| Total liabilities | $bn | [74.8](/filings/0001413329-25-000013.md) | [73.9](/filings/0001413329-24-000087.md) | [73.7](/filings/0001413329-24-000145.md) | [74.6](/filings/0001413329-24-000172.md) | [71.7](/filings/0001628280-26-005939.md) | [74.0](/filings/0001413329-25-000094.md) | [78.5](/filings/0001413329-25-000150.md) | [76.0](/filings/0001628280-25-046179.md) | [77.2](/filings/0001628280-26-066976.md) | [76.2](/filings/0001628280-26-027019.md) | [74.9](/filings/0001628280-26-049493.md) | [72.7](/filings/0001628280-26-066976.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [2.0](/filings/0001413329-25-000013.md) | [0.3](/filings/0001413329-24-000087.md) | [0.1](/filings/0001413329-24-000145.md) | [0.2](/filings/0001413329-24-000172.md) | [0.1](/filings/0001628280-26-005939.md) | [4.4](/filings/0001413329-25-000094.md) | [2.5](/filings/0001413329-25-000150.md) | [1.9](/filings/0001628280-25-046179.md) | [0.2](/filings/0001628280-26-066976.md) | [5.7](/filings/0001628280-26-027019.md) | [3.3](/filings/0001628280-26-049493.md) | [2.5](/filings/0001628280-26-066976.md) |
| Shareholders' equity | $bn | [(11.2)](/filings/0001413329-25-000013.md) | [(10.3)](/filings/0001413329-24-000087.md) | [(9.7)](/filings/0001413329-24-000145.md) | [(9.7)](/filings/0001413329-24-000172.md) | [(11.8)](/filings/0001628280-26-005939.md) | [(10.9)](/filings/0001413329-25-000094.md) | [(12.0)](/filings/0001413329-25-000150.md) | [(10.9)](/filings/0001628280-25-046179.md) | [(10.0)](/filings/0001628280-26-066976.md) | [(9.3)](/filings/0001628280-26-027019.md) | [(8.6)](/filings/0001628280-26-049493.md) | [(7.9)](/filings/0001628280-26-066976.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3,302 d](/filings/0001628280-26-005939.md) | [241](/filings/0001413329-25-000094.md) | [4,632 d](/filings/0001413329-25-000150.md) | [3,342 d](/filings/0001628280-25-046179.md) | [4,002 d](/filings/0001628280-26-005939.md) | [(350)](/filings/0001628280-26-027019.md) | [3,412 d](/filings/0001628280-26-049493.md) | [4,462 d](/filings/0001628280-26-066976.md) | [4,709 d](/filings/0001628280-26-005939.md) | [(399)](/filings/0001628280-26-027019.md) | [5,492 d](/filings/0001628280-26-049493.md) | [5,352 d](/filings/0001628280-26-066976.md) |
| Capital expenditure | $m | [311 d](/filings/0001628280-26-005939.md) | [417](/filings/0001413329-25-000094.md) | [370 d](/filings/0001413329-25-000150.md) | [379 d](/filings/0001628280-25-046179.md) | [278 d](/filings/0001628280-26-005939.md) | [404](/filings/0001628280-26-027019.md) | [356 d](/filings/0001628280-26-049493.md) | [365 d](/filings/0001628280-26-066976.md) | [444 d](/filings/0001628280-26-005939.md) | [353](/filings/0001628280-26-027019.md) | [380 d](/filings/0001628280-26-049493.md) | [382 d](/filings/0001628280-26-066976.md) |
| Dividends paid | $m | [2,023 d](/filings/0001628280-26-005939.md) | [2,037](/filings/0001413329-25-000094.md) | [2,027 d](/filings/0001413329-25-000150.md) | [2,027 d](/filings/0001628280-25-046179.md) | [2,106 d](/filings/0001628280-26-005939.md) | [2,116](/filings/0001628280-26-027019.md) | [2,106 d](/filings/0001628280-26-049493.md) | [2,107 d](/filings/0001628280-26-066976.md) | [2,295 d](/filings/0001628280-26-005939.md) | [2,307](/filings/0001628280-26-027019.md) | [2,297 d](/filings/0001628280-26-049493.md) | [2,299 d](/filings/0001628280-26-066976.md) |
| Share repurchases | $m | [0.0 d](/filings/0001413329-25-000013.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,553](/filings/0001413329-24-000087.md) | [1,553](/filings/0001413329-24-000145.md) | [1,554](/filings/0001413329-24-000172.md) | [1,555](/filings/0001413329-25-000094.md) | [1,556](/filings/0001413329-25-000150.md) | [1,556](/filings/0001628280-25-046179.md) | [1,557](/filings/0001628280-26-027019.md) | [1,558](/filings/0001628280-26-049493.md) | [1,558](/filings/0001628280-26-066976.md) | [1,559](/filings/0001628280-26-027019.md) | [1,560](/filings/0001628280-26-049493.md) | [1,560](/filings/0001628280-26-066976.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,558,655,629 at 2026-10-16, from the cover of the [10-Q filed 2026-10-23](/filings/0001628280-26-066976.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.